The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Highlighting unmet needs for CTCL
Evangelina Papadavid, MD, PhD, of the National and Kapodistrian University of Athens, Greece, and Marios Koumourtzis, MD, of the University of Athens Medical School, Andreas Syggros Hospital, Athens, Greece, discuss unmet needs in cutaneous T-cell lymphoma (CTCL), highlighting challenges around diagnosis, the need to identify accurate prognostic factors and the need for curative therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
